| Loren K Miyasaki, PHARM D | |
|
525 Healdsburg Ave, Healdsburg, CA 95448-3816 | |
| (707) 431-1119 | |
| (707) 431-0457 |
| Full Name | Loren K Miyasaki |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 525 Healdsburg Ave, Healdsburg, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548428410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26130 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Loren K Miyasaki, PHARM D 525 Healdsburg Ave, Healdsburg, CA 95448-3816 Ph: (707) 431-1119 | Loren K Miyasaki, PHARM D 525 Healdsburg Ave, Healdsburg, CA 95448-3816 Ph: (707) 431-1119 |
News Archive
Young children who do not display an ability to regulate their behavior or to delay gratification in exchange for a larger reward appear predisposed to gain extra weight by their pre-teen years, according to two reports published in the April issue of Archives of Pediatrics & Adolescent Medicine.
Researchers at BRIC, the University of Copenhagen, have discovered for the first time a protein normally found in the body that can act to prevent chronic tissue inflammation.
The pattern of brain alterations may be similar in several different neurodegenerative diseases, which opens the door to alternative therapeutic strategies to tackle these diseases
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.
› Verified 7 days ago
Mr. Dan Golden, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 455 Center St, Healdsburg, CA 95448 Phone: 707-433-3357 | |
Loreen Atallah, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1375 University Ave, Healdsburg, CA 95448 Phone: 707-431-6500 | |
Mr. David Hilty, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 Fax: 707-431-1403 | |
Joanna Christine Belmes Eslava, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 | |
Adrienne Tom, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 | |
Dr. Lucila Contreras Saldana, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 Fax: 707-431-1403 |